Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Electrospinning Company develops and manufactures medical-grade electrospun nanofibrous biomaterials and coatings used in medical devices. Their proprietary platforms enable the creation of advanced device coverings, biosynthetic scaffolds for tissue engineering/regeneration, resorbable implants with controlled degradation profiles, and permanent implantables. They operate as a contract development and manufacturing organization supporting global medtech innovators from concept through commercial scale-up. Their components have been incorporated into FDA-approved products since at least 2016.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Electrospinning Company.